XTalks

OCTOBER 26, 2021

The treatment came with an initial price tag of $39,000 per vial, which amounts to a total of $575,00 each year. Seizures occur due to the buildup of neurotoxins The condition can also cause other issues such as paralysis, insomnia and problems relating to the heart and lung. This leads to lowering of ALA and PBG levels.

Gene Silencing 98

Gene Silencing Gene Clinical Trials Clinical Trials 98

XTalks

SEPTEMBER 27, 2022

CALD is a rare, progressive neurodegenerative disease that mainly affects young boys. The record-breaking price tag of Skysona is not surprising for one-time gene therapies like it. Skysona was granted Orphan Drug designation, Rare Pediatric Disease designation and Breakthrough Therapy designation. Related: Bluebird’s $2.8M

FDA Approval 52

FDA Approval Gene Therapy Drugs Gene 52

pharmaphorum

AUGUST 17, 2020

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Joanna Carlish, managing director, financial services, Tag Americas. Virtual connections.

Regulation 93

Regulation Marketing Sales Branding 93

World of DTC Marketing

DECEMBER 13, 2021

As cancer survival rates rise, so do the price tags of life-saving treatments. Compare that with, say, treating heart disease. That’s why treating a heart attack may cost around $39,000. OPENING: American cancer patients spent more than $21 billion on their care in 2019. billion included out-of-pocket costs of $16.22

Drugs 55

Drugs FDA Approval Medicine Containment 55

XTalks

DECEMBER 21, 2022

Bluebird is also now back on track in evaluating its candidate gene therapy for sickle cell disease (SCD) after the FDA lifted a clinical hold on studies of the drug this month. There is also generally a low cost of return for gene therapies, particularly those for rare diseases. million for a single infusion.

Life Science 52

Life Science Gene Therapy Gene Clinical Trials 52

Delveinsight

JULY 22, 2020

The overall focus of IoT is to prevent disease rather than curing it. The IoT can provide real-time data of patient’s vital stats such as heart rate, blood pressure, temperature, body weight, oxygen saturation level, blood sugar, kidney functioning and many others. CVD & Heart Related Diseases.

Doctors 59

Doctors Doctor Marketing Production 59

XTalks

MARCH 22, 2023

The years that followed have seen a rise in large pharma companies acquiring much smaller biopharmas with a narrow focus on rare disease therapeutic development. The proton-pump inhibitor is designed to reduce stomach acid levels, thereby treating digestive conditions like gastroesophageal reflux disease (GERD).

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

pharmaphorum

FEBRUARY 26, 2021

Some of the most well-known Janssen products include diarrhoea treatment, Immodium (loperamide), antipsychotic Risperdal (risperidone) and Alzheimer’s disease drug, Reminyl (galantamine). This move revolutionised cardiology – coronary stents keep vessels open so blood can flow to the heart. billion the following February.

Sales 125

Sales Production Pharma Companies Marketing 125

Pharmaceutical Technology

NOVEMBER 30, 2022

In 1997, the World Health Organization (WHO) classified obesity as a chronic disease. High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions. compared to a 5.1%

Drugs 264

Drugs Manufacturing Hormones Contract Manufacturing 264

Pharmaceutical Technology

NOVEMBER 30, 2022

In 1997, the World Health Organization (WHO) classified obesity as a chronic disease. High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions. compared to a 5.1%

Drugs 246

Drugs Manufacturing Hormones Contract Manufacturing 246